Staffordshire Urology Clinic surgeon Lyndon Gommersall explains the new Da Vinci Si Robotic surgical system.
If you are worried about prostate cancer or wish to discuss private assessment or treatment of prostate cancer please contact the North Staffordshire Nuffield Hospital on 01782 382507 and ask for an appointment with Mr Christopher Luscombe of Mr Lyndon Gommersall.
Since the launch of the Staffordshire Urology Clinic website 23,500 have been recorded, with 47,000 page views.
Staffordshire Urology clinic surgeons first in Staffordshire to perform robotic surgery for prostate cancer.
Christopher Luscombe and Lyndon Gommersall are extremely excited about this innovative development for the population of Staffordshire.
The 2 day BAPU course was held at Cambridge Queens College. National experts discussed all aspects of paediatric Urology.
The Staffordshire Urology Clinic website has had 15,000 visitors with over 32,000 page views.
The website has attracted 14,685 visits in its first 2 years. 12,304 of these were from unique visitors. There have been 31,455 page views.
The new overactive bladder drug Mirabegron (Betmiga, Astellas) has recently been added to the joint Staffordshire drug formulary. This breakthrough drug in the treatment of overactive bladder and urgency urinary incontinence causes active relaxation of bladder muscle contraction and has been shown to reduce the number of times a patient voids during the day and decreases the number of incontinence episodes each day. This once a day treatment is the latest treatment for this debilitating condition with minimal side effects. At the Staffordshire Urology Clinic we continue to offer bladder botox injections, peripheral tibial nerve stimulation (PTNS) and in depth empathetic assessment, advice and treatment for all patients with bladder dysfunction.
Lyndon Gommersall Consultant Urological Surgeon at the Staffordshire Urology Clinic joined colleagues from Mediwatch to train JCB occupational health nurses to perform the finger prick PSAwatch point of care PSA blood test. This innovative project to test JCB employees over the age of 50 years at their place of work for prostate cancer has been developed in line with the national prostate cancer risk management programme. Promoting Men’s Health in the workplace is an important method of improving men’s early attendance to their doctor with symptoms that can lead to a diagnosis of cancer. By offering an information leaflet and the PSA point of care blood test men will get instant reassurance if their PSAwatch blood test is normal and have an ‘at work’ review by a Consultant Urological Specialist if a test is abnormal or other concerns are raised. For more information about PSA blood testing in the workplace please contact us
Mr Lyndon Gommersall recently hosted a discussion about prostate cancer at JCB headquarters. PSA testing and especially the new rapid PSAwatch test were the focus of discussions.